American Journal of Food and Nutrition
ISSN (Print): 2374-1155 ISSN (Online): 2374-1163 Website: Editor-in-chief: Mihalis Panagiotidis
Open Access
Journal Browser
American Journal of Food and Nutrition. 2019, 7(3), 107-112
DOI: 10.12691/ajfn-7-3-5
Open AccessArticle

A Single Arm Trial in Treatment of CKD Patients with Sodium Copper Chlorophyllin Formulation

Suresh Patankar1, Atul Sajgure1, Chitra Savangikar2, , Vasant Savangikar2, Sharvari Rangnekar3 and Milind Gharpure4

1ACE Multispecialty Hospital, S No- 32/2A, Erandwana, GulawaniMaharaj Road, Near Mehandale Garage, Opp. Hotel Abhishek, Pune, Maharashtra 411004 India

2PhytabolitesNeutraceuticals Pvt. Ltd. 4, Tapasvi Apt. Prasanna colony, Indiranagar, Nashik 422009 India

3Quest Clinical Services, 14, Samata, Ganeshnagar, Chinchwad, Pune, Maharashtra-411033 India

4Thinq Pharma –CRO Pvt. Ltd., Road no. 9, Wagle estate MIDC, Thane, Mumbai400604 India

Pub. Date: October 28, 2019

Cite this paper:
Suresh Patankar, Atul Sajgure, Chitra Savangikar, Vasant Savangikar, Sharvari Rangnekar and Milind Gharpure. A Single Arm Trial in Treatment of CKD Patients with Sodium Copper Chlorophyllin Formulation. American Journal of Food and Nutrition. 2019; 7(3):107-112. doi: 10.12691/ajfn-7-3-5


In a prospective, single arm study of 34 Chronic Kidney Disease (CKD) patients in a trial of 90 days wherein patients got standard-of-care treatment and liquid composition containing Sodium Copper Chlorophyllin, the Investigational Product (IP), as add-on treatment for first 60 days and patients were ‘off’ the IP for last 30 days. Significant reduction in serum creatinine, Blood Urea and Uric acid level and significant improvement in estimated Glomerular Filtration Rate (eGFR), and Health related criteria for quality of life were observed in 60 days’ period of administration. eGFR remained significantly higher on 90th day than 0 day despite withdrawal of IP after 60 days. These observations suggest partial/limited reversal of lost kidney function as a lingering effect of the IP. Both these are first observations opening up new avenues for improving life of CKD patients. This is first clinical trial report of an orally consumed product that decreases serum creatinine and also actually improved health related quality of life within 60 days and a surprising evidence that suggests significant degree of restoration of kidney function in the progressively degenerative disease CKD. This clinical trial opens opportunities for managing CKD that were never available so far.

chronic kidney disease copper chlorophyllin creatinine blood urea quality of life

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Chernomorsky SA, Segelman AB. Biological activities of chlorophyll derivatives. N J Med. 1988; 85(8): 669-673.
[2]  Smith RG. Enzymatic debriding agents: an evaluation of the medical literature. Ostomy Wound Manage. 2008; 54(8): 16-34.
[3]  Weir D, Farley KL. Relative delivery efficiency and convenience of spray and ointment formulations of papain/urea/chlorophyllin enzymatic wound therapies. J Wound Ostomy Continence Nurs. 2006; 33(5): 482-490.
[4]  Chimploy K, Diaz GD, Li Q, et al. E2F4 and ribonucleotidereductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin. Int J Cancer. 2009; 125(9):2086-94.
[5]  Tachino N, Guo D, Dashwood WM, Yamane S, Larsen R, Dashwood R. Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen. Mutat Res. 1994 Jul 16; 308(2): 191-203.
[6]  Kamat JP, Boloor KK, Devasagayam TP. Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim Biophys Acta. 2000; 1487(2-3): 113-127.
[7]  Kumar SS, Shankar B, Sainis KB. Effect of chlorophyllin against oxidative stress in splenic lymphocytes in vitro and in vivo. Biochim Biophys Acta. 2004; 1672(2): 100-111.
[8]  Yun CH, Jeong HG, Jhoun JW, Guengerich FP. Non-specific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes. Carcinogenesis. 1995; 16(6): 1437-1440.
[9]  Dingley KH, Ubick EA, Chiarappa-Zucca ML, et al. Effect of dietary constituents with chemopreventive potential on adduct formation of a low dose of the heterocyclic amines PhIP and IQ and phase II hepatic enzymes. Nutr Cancer. 2003; 46(2):212-221.
[10]  Kephart JC. Chlorophyll derivatives - their chemistry, commercial preparation and uses. Econ Bot. 1955; 9: 3-38.
[11]  Yang UJ, Park TS, Shim SM. Protective effect of chlorophyllin and lycopene from water spinach extract on cytotoxicity and oxidative stress induced by heavy metals in human hepatoma cells. J Toxicol Environ Health A. 2013; 76(23): 1307-15.
[12]  Gao F, Hu XF Analysis of the therapeutic effect of sodium copper chlorophyllin tablet in treating 60 cases of leukopenia. Chin J Integr Med 2005 Dec; 11(4): 279-82.
[13]  WO2016116950 Chlorophyll composition ngikar%29&prevFilter=&sortOption=Pub+.
[14]  CKD EPI Equation for Estimating GFR Expressed for Specified Race, Sex and Serum Creatinine in mg/dL (From Ann Intern Med 2009; 150: 604-612.
[15]  Melanie L.R. Wyld, Steven J. Chadban, and Rachael L. Morton . Improving our understanding of quality of life in CKD. Am J Kidney Dis. 2016: 67(6): 820-821.
[16]  Poppe C, Crombez G, Hanoulle I, Vogelaers D, Petrovic M. Improving quality of life in patients with chronic kidney disease: influence of acceptance and personality. Nephrol Dial Transplant. 2013 Jan; 28(1): 116-21. Epub 2012 Jul 20.
[17]  Berthoux F1, Bartiromo M. How to improve quality of life in patients with chronic kidney disease: a personal view. J Nephrol. 2008 Mar-Apr; 21Suppl 13: S7-8.